Scholarlink

Objectives <p>Because the ankle–foot complex is a frequent target of cryotherapy in sports medicine, establishing location-specific duration guidance has practical clinical relevance. Thus, the aim of this study was to determine how ankle-applied cold compression duration shapes microvascular perfusion at the foot dorsum, cold-induced vasodilation (CIVD), post-cooling hyperaemia, and analgesia, and to identify a pragmatic exposure window that maximizes vasoconstriction and pressure-pain threshold (PPT) while limiting CIVD/hyperaemia in healthy adults.</p> Methods <p>Prospective, randomized, controlled, parallel-group trial with a repeated-measures duration factor using an ankle–foot cuff. Sixty healthy volunteers were allocated 1:1 to Active cold compression (ACC; ~3&#xa0;°C, 5–75 mmHg) or sham (shamCC; 20&#xa0;°C, ~ 15 mmHg). Each participant completed four sessions (5, 10, 15, 20&#xa0;min), order randomized with ≥ 7-day washouts. Primary outcomes were laser-Doppler perfusion indices at the foot dorsum; secondary outcome was PPT by algometry.</p> Results <p>Minimum perfusion (nadir) showed a strong duration effect and a condition×group interaction; ACC achieved lower perfusion than sham at 5, 10, 15, and 20&#xa0;min (all <i>p</i> &lt; 0.001), with progressive nadir reductions from 10→20&#xa0;min in ACC (<i>p</i> ≤ 0.018). Time-to-nadir decreased with longer exposures (main effect <i>p</i> &lt; 0.001). CIVD at the foot increased with duration and was higher in ACC at 15&#xa0;min (<i>p</i> = 0.004) and 20&#xa0;min (<i>p</i> &lt; 0.001). Post-cooling hyperaemia (AUC) showed large effects for duration and group; between-group differences favored ACC at 0–15&#xa0;min for all durations (all <i>p</i> ≤ 0.001), with stepwise increases from 5→20&#xa0;min in ACC (all <i>p</i> &lt; 0.001). Post-peak perfusion was greater with ACC at 10–20&#xa0;min (all <i>p</i> &lt; 0.001). At post-intervention PPT was higher with ACC at 5&#xa0;min (<i>p</i> = 0.005), 10&#xa0;min (<i>p</i> &lt; 0.001), 15&#xa0;min (<i>p</i> &lt; 0.001), and 20&#xa0;min (<i>p</i> &lt; 0.001). Within ACC, 10, 15, and 20&#xa0;min produced similar (and greater) PPT improvements, each exceeding 5&#xa0;min (all <i>p</i> ≤ 0.001).</p> Conclusion <p>ACC elicited dose-dependent vasoconstriction and robust hypoalgesia, with PPT improvements plateauing by 10&#xa0;min. Because CIVD and post-cooling hyperaemia escalated at ≥ 15&#xa0;min, a 10-minute ACC bout best balanced analgesia with vascular control, limiting disproportionate rebound perfusion and preserving a physiological equilibrium between vasoconstriction and vascular reopening; extending to 15&#xa0;min can be reserved for cases needing marginal additional relief.</p> Trial registration <p>ISRCTN90040217; date: 25/05/2023.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Time-dependent microvascular and analgesic responses to cold compression in healthy adults: identifying the optimal cooling duration for recovery

  • 期刊论文

  • 发表日期：

    2026年1月31日

查看全文
  • Robert Trybulski,
  • Aleksandra Żebrowska,
  • Yaroslav Svyshch,
  • Andriy Vovkanych,
  • Gracjan Olaniszyn,
  • Jakub Taradaj

摘要

Objectives

Because the ankle–foot complex is a frequent target of cryotherapy in sports medicine, establishing location-specific duration guidance has practical clinical relevance. Thus, the aim of this study was to determine how ankle-applied cold compression duration shapes microvascular perfusion at the foot dorsum, cold-induced vasodilation (CIVD), post-cooling hyperaemia, and analgesia, and to identify a pragmatic exposure window that maximizes vasoconstriction and pressure-pain threshold (PPT) while limiting CIVD/hyperaemia in healthy adults.

Methods

Prospective, randomized, controlled, parallel-group trial with a repeated-measures duration factor using an ankle–foot cuff. Sixty healthy volunteers were allocated 1:1 to Active cold compression (ACC; ~3 °C, 5–75 mmHg) or sham (shamCC; 20 °C, ~ 15 mmHg). Each participant completed four sessions (5, 10, 15, 20 min), order randomized with ≥ 7-day washouts. Primary outcomes were laser-Doppler perfusion indices at the foot dorsum; secondary outcome was PPT by algometry.

Results

Minimum perfusion (nadir) showed a strong duration effect and a condition×group interaction; ACC achieved lower perfusion than sham at 5, 10, 15, and 20 min (all p < 0.001), with progressive nadir reductions from 10→20 min in ACC (p ≤ 0.018). Time-to-nadir decreased with longer exposures (main effect p < 0.001). CIVD at the foot increased with duration and was higher in ACC at 15 min (p = 0.004) and 20 min (p < 0.001). Post-cooling hyperaemia (AUC) showed large effects for duration and group; between-group differences favored ACC at 0–15 min for all durations (all p ≤ 0.001), with stepwise increases from 5→20 min in ACC (all p < 0.001). Post-peak perfusion was greater with ACC at 10–20 min (all p < 0.001). At post-intervention PPT was higher with ACC at 5 min (p = 0.005), 10 min (p < 0.001), 15 min (p < 0.001), and 20 min (p < 0.001). Within ACC, 10, 15, and 20 min produced similar (and greater) PPT improvements, each exceeding 5 min (all p ≤ 0.001).

Conclusion

ACC elicited dose-dependent vasoconstriction and robust hypoalgesia, with PPT improvements plateauing by 10 min. Because CIVD and post-cooling hyperaemia escalated at ≥ 15 min, a 10-minute ACC bout best balanced analgesia with vascular control, limiting disproportionate rebound perfusion and preserving a physiological equilibrium between vasoconstriction and vascular reopening; extending to 15 min can be reserved for cases needing marginal additional relief.

Trial registration

ISRCTN90040217; date: 25/05/2023.